Guidelines for the early evaluation and management of chronic kidney disease in China.
10.3760/cma.j.cn112138-20221013-00755
- Collective Name:Chinese Preventive Medicine Association for Kidney Disease
- Publication Type:Journal Article
- MeSH:
Adult;
Humans;
Renal Insufficiency, Chronic/therapy*;
Prevalence;
China/epidemiology*
- From:
Chinese Journal of Internal Medicine
2023;62(8):902-930
- CountryChina
- Language:Chinese
-
Abstract:
Chronic kidney disease (CKD) has become a serious public health concern that endangers human health on a global scale. In China, the prevalence of CKD in adults is 10.8%; however, public awareness and the diagnostic rates of CKD in the Chinese population are relatively low. Moreover, China has not yet established a national CKD screening system or developed standardized diagnostic protocols and treatment pathways. Therefore, there is an urgent need to strengthen the prevention and control of CKD and promote the management of this disease. These guidelines were initiated by the Chinese Preventive Medicine Association for Kidney Disease. The quality of evidence and guideline recommendation were determined by applying the Oxford Centre for Evidence-Based Medicine (CEBM) System. These new guidelines describe 38 recommendations that aim to standardize the early screening, management, diagnosis and treatment of CKD, thus promoting the integrated prevention and control of kidney disease in China.
